Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference55 articles.
1. Delivering benefits at speed through real-world repurposing of off-patent drugs: the COVID-19 pandemic as a case in point;Rogosnitzky;JMIR Public Health Surveill,2020
2. Exercise as medicine for COVID-19: An ACE in the hole?;Heffernan;Med Hypotheses,2020
3. Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein;McBride;Virology,2010
4. Ehrlich A, Uhl S, Ioannidis K, Hofree M, tenOever BR, Nahmias Y. The SARS-CoV-2 Transcriptional Metabolic Signature in Lung Epithelium. SSRN Cell Metabolism. Available at SSRN: https://ssrn.com/abstract=3650499 or https://doi.org/10.2139/ssrn.3650499.
5. Impairment of Fatty Acid Oxidation in Alveolar Epithelial Cells Mediates Acute Lung Injury;Cui;Am J Respir Cell Mol Biol,2019
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID‐19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples;British Journal of Clinical Pharmacology;2024-05-31
2. Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study;Pharmacological Reports;2023-08-16
3. Determining human-coronavirus protein-protein interaction using machine intelligence;Medicine in Novel Technology and Devices;2023-06
4. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease;Medicinal Research Reviews;2023-04-29
5. The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy;Frontiers in Immunology;2023-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3